Randomised trial in 28 overweight/obese men (40-70y, BMI 25-37) on a 12-week carbohydrate-restricted diet, randomised to 3 whole eggs/day (640 mg additional dietary cholesterol) or no eggs. HDL-C rose from 1.23±0.39 to 1.47±0.38 mmol/L (p<0.01) in the egg group and did not change in the no-egg group; the LDL:HDL ratio was maintained similarly across both hyper- and hypo-absorbers of dietary cholesterol. Read alongside carbohydrate restriction (which itself raises HDL), so the egg-specific increment is a same-background comparison, not egg vs. a low-fat/high-carb control. relevance_note: Egg-industry-funded whole-egg RCT showing an HDL-raising, LDL-neutral average lipid response — core pro-egg mechanism anchor, with disclosed motivatedness.
Methodology
Randomized trial in 28 overweight/obese men (age 40-70, BMI 25-37) on a 12-week carbohydrate-restricted diet (10-15% energy from carbohydrate), randomized to 3 whole eggs/day (640 mg/day additional dietary cholesterol; EGG) or an energy-matched egg substitute with 0 cholesterol (SUB). Subjects classified as hyper- vs hypo-absorbers of dietary cholesterol. (Depth-limited: publisher full text returned HTTP 403; extracted from the complete abstract, the step-2 summary, and corroborated numbers.)
Results
O-97 - 3 whole eggs-day raised HDL-C in overweight men on a carbohydrate-restricted diet, while egg substitute did not
The egg-specific HDL rise is isolated by the substitute group (same CRD background, no eggs) showing no HDL change - so the increment is attributable to the eggs, not the diet background alone (though the CRD itself raises HDL, making this a same-background comparison rather than egg-vs-low-fat control).
Link to originalMethodology
Randomized trial in 28 overweight/obese men (age 40-70, BMI 25-37) on a 12-week carbohydrate-restricted diet (10-15% energy from carbohydrate), randomized to 3 whole eggs/day (640 mg/day additional dietary cholesterol; EGG) or an energy-matched egg substitute with 0 cholesterol (SUB). Subjects classified as hyper- vs hypo-absorbers of dietary cholesterol. (Depth-limited: publisher full text returned HTTP 403; extracted from the complete abstract, the step-2 summary, and corroborated numbers.)
Link to original
O-98 - LDL-C and the LDL-HDL ratio did not change with egg intake, including in dietary-cholesterol hyper-absorbers
Despite 640 mg/day added dietary cholesterol, LDL-C did not rise and the atherogenic LDL:HDL ratio was preserved - and this held across cholesterol-absorption phenotypes, arguing the average egg lipid response is not offset by an LDL penalty.
Link to original
O-99 - On the carbohydrate-restricted diet, triglycerides, body weight, and metabolic-syndrome prevalence all fell across both groups
These improvements occurred in both groups and are carbohydrate-restriction (background-diet) effects rather than egg-specific; recorded to keep the egg-attributable signal (the HDL rise) distinguished from the CRD background.
Link to original
Discussion
H-40 - Whole eggs on a carbohydrate-restricted diet produce a net-favorable-neutral lipid response (HDL up, LDL-HDL preserved) even in hyper-absorbers
The pro-egg lipid-mechanism candidate answer. Uncertain: n=28, short, egg-industry funded (Fernandez lab), and confounded by a carbohydrate-restricted background that independently raises HDL.
Link to original
A-34 - HDL rose while LDL and the LDL-HDL ratio held across absorber phenotypes, so the egg lipid effect is neutral-to-favorable rather than atherogenic
The LDL:HDL ratio is a standard atherogenicity summary: a lipid change is favorable if it lowers the ratio, harmful if it raises it. Here HDL-C rose (~1.23 to 1.47 mmol/L; O-97) while LDL-C did not change (O-98), so the ratio numerator was flat and the denominator rose — arithmetically the ratio falls or holds, i.e., moves in the non-atherogenic direction. The load-bearing subtlety is the absorber stratification: a common worry is that dietary-cholesterol “hyper-absorbers” would show an LDL rise that offsets the HDL benefit; the observation that the LDL:HDL ratio was maintained similarly in both hyper- and hypo-absorbers (O-98) blocks that escape route, showing the neutral-to-favorable pattern is not an artifact of averaging over a harmed subgroup and a benefited subgroup. Hence the data support a neutral-to-favorable net lipid classification for whole eggs on this background (H-40). Caveat carried into H-40, not this argument: the CRD background independently raises HDL and lowers TG, and n is small, so the classification is about direction/sign, not effect size in a general population.
Validity verdict (step 6)
status: approved, checked. Reconstruction: explicit premise is that the LDL:HDL ratio is a valid atherogenicity summary of a lipid change (favorable if it falls, harmful if it rises); the step is: HDL up + LDL flat ⇒ ratio falls-or-holds ⇒ moves in the non-atherogenic direction; and holding within BOTH absorber strata ⇒ the pattern is not an averaging artifact masking a harmed subgroup ⇒ neutral-to-favorable, not atherogenic. Conditional on the ratio-as-metric premise the arithmetic and the subgroup logic trace cleanly. Note the “neutral-to-favorable” range maps exactly onto the argument’s own “falls or holds” hedge (holds = neutral, falls = favorable), so the conclusion is not an overclaim relative to O-98’s “ratio did not change” — it does not need to be corrected down to “neutral” only. Undercutting-defeater probe: the strongest defeater — that LDL:HDL omits ApoB/LDL particle number and HDL-raising is not reliably cardioprotective (CETP/niacin RCT failures), so a preserved ratio could still be atherogenic — attacks the premise that the ratio validly summarizes atherogenicity, and the conclusion is explicitly scoped to the “lipid effect / lipid classification,” not to clinical outcome. Within that scope the premise is granted and the step holds. checked: elementary arithmetic plus stratum logic, author-blind.
Link to original